Morgan Stanley Maintains Equal-Weight on Sarepta Therapeutics, Raises Price Target to $135
SRPTSeptember 8, 2022
Read more →Sarepta Therapeutics: Q1 Earnings Insights
SRPTSarepta Therapeutics (NASDAQ:SRPT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
May 4, 2022
Read more →Sarepta Therapeutics Q1 EPS $(1.20) Beats $(1.27) Estimate, Sales $210.83M Beat $206.44M Estimate
SRPTMay 4, 2022
Read more →Sarepta Therapeutics's Earnings: A Preview
SRPTSarepta Therapeutics (NASDAQ:SRPT) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Sarepta Therapeutics will report an earnings per share (EPS) of $-1.27.
May 3, 2022
Read more →